BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1372585)

  • 21. Peroxisomal disorders: clinical commentary and future prospects.
    Wilson GN; Holmes RD; Hajra AK
    Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G.
    Muntau AC; Mayerhofer PU; Paton BC; Kammerer S; Roscher AA
    Am J Hum Genet; 2000 Oct; 67(4):967-75. PubMed ID: 10958759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereological analysis of peroxisomes and mitochondria in intestinal epithelium of patients with peroxisomal deficiency disorders: Zellweger's syndrome and neonatal-onset adrenoleukodystrophy.
    Black VH; Cornacchia L
    Am J Anat; 1986 Sep; 177(1):107-18. PubMed ID: 3776884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly.
    Okamoto H; Suzuki Y; Shimozawa N; Yajima S; Masuno M; Orii T
    Exp Cell Res; 1992 Aug; 201(2):307-12. PubMed ID: 1639130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peroxisomes and peroxisomal diseases].
    Petelenz M; Gonciarz Z; Grzybek H; Panz B
    Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
    Poulos A; Sharp P; Johnson D
    Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.
    Poll-The BT; Saudubray JM; Ogier HA; Odièvre M; Scotto JM; Monnens L; Govaerts LC; Roels F; Cornelis A; Schutgens RB
    Eur J Pediatr; 1987 Sep; 146(5):477-83. PubMed ID: 2445576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes.
    Stanczak H; Kremser K; Singh AK; Ashcraft J; Stanley W; Singh I
    Hum Hered; 1992; 42(3):172-8. PubMed ID: 1511996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
    Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
    Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.
    Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G
    Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals.
    Tateishi K; Okumoto K; Shimozawa N; Tsukamoto T; Osumi T; Suzuki Y; Kondo N; Okano I; Fujiki Y
    Eur J Cell Biol; 1997 Aug; 73(4):352-9. PubMed ID: 9270878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic peroxisomes are deficient in infantile refsum disease: a cytochemical study of 4 cases.
    Roels F; Cornelis A; Poll-The BT; Aubourg P; Ogier H; Scotto J; Saudubray JM
    Am J Med Genet; 1986 Oct; 25(2):257-71. PubMed ID: 2430454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts.
    Wiemer EA; Brul S; Just WW; Van Driel R; Brouwer-Kelder E; Van Den Berg M; Weijers PJ; Schutgens RB; Van Den Bosch H; Schram A
    Eur J Cell Biol; 1989 Dec; 50(2):407-17. PubMed ID: 2697558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the peroxin Pex26p responsible for peroxisome biogenesis disorders of complementation group 8 impair its stability, peroxisomal localization, and interaction with the Pex1p x Pex6p complex.
    Furuki S; Tamura S; Matsumoto N; Miyata N; Moser A; Moser HW; Fujiki Y
    J Biol Chem; 2006 Jan; 281(3):1317-23. PubMed ID: 16257970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect.
    Guerroui S; Aubourg P; Chen WW; Hashimoto T; Scotto J
    Biochem Biophys Res Commun; 1989 May; 161(1):242-51. PubMed ID: 2471528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.
    Zellweger H; Maertens P; Superneau D; Wertelecki W
    South Med J; 1988 Mar; 81(3):357-64. PubMed ID: 2450404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
    Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
    J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.